Search

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.

While BRCA genes garner most of the public's attention, they're not the only cancer-predisposition genes doctors test for.

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 14-19 in Orlando, Florida.

Fifth-year graduate student Semanti Mukherjee was awarded the Chairman's Prize for her first-author paper that was accepted for publication in the May 2011 issue of Human Heredity.

MSK patients that need urgent care may receive care closer to home. That’s when MSK's 34 Shared Care nurses — led by Carol Gemignani — step in.

New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples.

Increased breast density, but not BMI, is an additional risk factor for breast cancer in women with lobular carcinoma in situ (LCIS).

Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.